Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
Non-melanoma skin cancer (NMSC) are appearing on their skin regularly. My folks don’t like the freckles, AK’s dry patches, etc.
Wearing round bandaids on their faces makes them feel self-conscious. Both my parents have been outdoorsy people all their lives. It makes sense that their frequent exposure to the sun over the past 7 decades now results in frequent NMSC.
Non-Melanoma Skin Cancer at a Glance-
The fact is that NMSC is “rarely fatal” according to the study below. And further, “lesions can have a significant impact on the quality of life for the afflicted patients- especially the elderly.”
NMSC patients like my folks should understand that there are simple, inexpensive therapies to reduce the risk of NMSCs. Studies show that several supplements reduce the risk of NMSC or a second NMSC.
Let me be clear. MOHS surgery is an excellent therapy for removing the NMSC on your face. But if you want to be proactive in your NMSC you may want to supplement with the above evidence-based, non-toxic therapies.
To learn more about other evidence-based therapies that can help prevent the development of non-melanoma skin cancer or relapse, please watch the short video below:
Have you been diagnosed with skin cancer? Please scroll down the page, post a question or comment and I will reply to you ASAP.
“When selecting patients for NMSC treatment, physicians should consider if the lesion affects the patient’s functionality…
During the opening session of the meeting, Michael Renzi, M.D., said that although NMSC is rarely a fatal diagnosis, these lesions can have a significant impact on the quality of life for afflicted patients — especially the elderly…
NMSC treatment is most often effectively treated with Mohs micrographic surgery, but it’s not always a practical option. So, in this study, researchers examined how different treatments for nonmelanoma skin cancer were applied to elderly patients with low functionality…
The study included 203 patients, 75 years old or older, who were undergoing biopsy for suspected NMSC and who met the criteria for Mohs micrographic surgery. The dermatologist choosing the treatment was blinded to the functionality assessment…
Physicians should “utilize less invasive modalities for patients with poor functional status, even when the tumor meets the appropriate use criteria (AUC) for Mohs micrographic surgery (MMS),”